Breast Cancer Molecular Testing (BPA) Notice of Intent to Sole Source
Closed Pre-Solicitation Posted
- Solicitation number
- 36C10X24Q0235
- Agency
-
VA Strategic Acquisition Center Frederick
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Frederick, Maryland 21703, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Strategic Acquisition Center - Frederick intends to issue a firm-fixed price (FFP) Blanket Purchase Agreement (BPA) on a sole-source basis for the procurement of the Oncotype Dx Breast Cancer Assay from Exact Sciences Corporation. This unique and highly specialized laboratory test is required to predict chemotherapy benefit. The applicable NAICS code is 621511 - Medical Laboratories, with a size standard of $41.5 million. The Product Service Code is Q301 - Medical - Laboratory Testing. The agency anticipates negotiating and awarding the BPA to Exact Sciences Corporation by July 15, 2024. Interested parties believing they can satisfy the requirement must submit written capability statements by June 7, 2024 at 4:00 PM EST.
There is no set-aside designation for this procurement. Exact Sciences Corporation is the only source capable of providing the Oncotype Dx Breast Cancer Assay at the required level of quality. The agency has not provided any information about award values or budget ranges. The only numerical detail provided is the anticipated award date of July 15, 2024.
Notice text
The Department of Veterans Affairs Strategic Acquisition Center – Frederick intends to issue a firm-fixed price (FFP) Blanket Purchase Agreement (BPA) on a sole-source basis. The statutory authority permitting other than full and open competition for this procurement is 41 USC 3304(a)(1) as implemented by the Federal Acquisition Regulation (FAR) subpart is FAR 8.405-6(a)(1)(B), which states, “Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized.”
The requirement is for the procurement of Oncotype Dx Breast Cancer Assay (trademarked by Genomic Health/Exact Sciences) to predict chemotherapy benefit. The exact test is offered only through Exact Sciences, Corporation, 5505 Endeavor Lane Madison, WI 53719.
The applicable North American Industry Classification System (NAICS) code 621511– Medical Laboratories is the most appropriate for this requirement. The size standard is $41.5 million. The Product Service Code (PSC) is Q301 – Medical – Laboratory Testing. SAC-F anticipates negotiating and awarding a firm-fixed price BPA to Exact Sciences Corporation for this requirement by July 15, 2024.
Please refer to attached document: Presolicitation Intent to Sole Source_36C10X24Q0235.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--NEW – STX Specialized Molecular Residual Disease Testing | Veterans Integrated Service Network 17 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 6640--Notice of Intent to Sole Source - Roche Tests - NIHCS | Veterans Integrated Service Network 10 | No set-aside | |
| Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334) | Veterans Integrated Service Network 2 | No set-aside | |
| 7A21--Siemens UniPOC Licenses and Service | VA Technology Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity